Velsipity-Etrasimod
Velsipity is a once-daily pill for adults with moderately to severely active ulcerative colitis. It modulates S1P receptors to reduce inflammation and maintain remission.
Rivfloza-Nedosiran
Rivfloza is a once-monthly injection for children more than 2 years old and adults with primary hyperoxaluria type 1. It lowers urine oxalate levels by silencing a liver enzyme, helping protect kidney function.
Izervay-Avacincaptad Pegol
Izervay is a monthly injection into the eye to treat geographic atrophy caused by age-related macular degeneration. It slows vision loss by targeting a key protein involved in retinal cell death.
Litfulo-Ritlecitinib
Litfulo is an oral treatment for adults and adolescents aged 12 and older with severe alopecia areata. It helps regrow scalp hair by blocking immune pathways that attack hair follicles.
Vanflyta-Quizartinib
Vanflyta is an oral medicine used with chemotherapy for adults newly diagnosed with FLT3‑ITD positive acute myeloid leukemia. It continues working as a maintenance therapy to help keep the cancer in check.
Xdemvy-Lotilaner
Xdemvy is an eye drop treatment that targets and kills Demodex mites to treat blepharitis (eyelid inflammation). Apply twice daily for six weeks to clear up symptoms.
Zelsuvmi-Berdazimer
Zelsuvmi is a topical gel applied to molluscum contagiosum skin lesions in patients aged one year and older. The gel releases nitric oxide to clear lesions and is the only at-home prescription treatment for this viral infection.
Zurzuvae-Zuranolone
Zurzuvae is a 14-day oral pill for adults with postpartum depression, offering rapid improvement in depressive symptoms. It helps new mothers regain mood balance after childbirth.
Exblifep-Cefepime And Enmetazobactam
Exblifep is an antibiotic drug used in adults to treat complicated urinary tract infections, such as kidney infections, hospital-acquired pneumonia, including ventilator-associated pneumonia, and bacteraemia when associated or suspected to be associated with these infections.
Rezdiffra-Resmetirom
Rezdiffra is a prescription medication indicated for the treatment of non-cirrhotic non-alcoholic steatohepatitis (NASH) in individuals with mild to severe hepatic fibrosis. It is used to promote improved liver health in conjunction with a balanced diet and consistent exercise.
